You have activated the high contrast version of the site. For more info on this topic, please visit this page.
Numerous technological advances have enabled significant progress to be the made in the area of heart surgery, whether it’s to repair or to replace a section of it. Cardiovascular Surgery has focused its efforts on fundamental research with the use of biodegradable materials.
The Cardiovascular Surgery Division, HUG has therefore developed the first biodegradable mitral annulus that received the CE label in 2005. In terms of valvular substitutes, the tendency is to use biodegradable, biological materials or synthetic ones, in such a way that over time, they will disintegrate and be reabsorbed naturally in the patient’s tissue. Furthermore, Vascular Surgery uses artificial vessels (endo-prosthesis) or auto-transplants to repair damaged vessels.
The Marc-Claude Marti Award 2012 was presented on February 28, 2013 to Dr. Damiano MUGNAI, a Vascular and Endovascular Surgeon, Senior Resident of the Cardiovascular Surgery Division, for his “Experimental Study on Small Caliber Biodegradable Vascular Prostheses”.
For many years, the Experimental Research Group in Cardiovascular Surgery at HUG, under the leadership of Dr. Beat Walpoth is interested in creating and using vascular prostheses. These studies were conducted in collaboration with the group from the Geneva-Lausanne School of Pharmacy (EPGL) with support from the Swiss National Foundation and is particularly focused on biomedical engineering.
To learn more about research on biodegradable materials, watch “Du high tech au bio : L’art de réparer le corps" (FR) (Pulsation TV February 2013)